Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2018-11-01
2019-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Prevalence and intensity of pain
2. Prevalence and intensity of itching
3. Occurrence and intensity of local redness and swelling
4. Occurrence and intensity of local changes in skin temperature and blood flow
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
IV Lidocaine Infusion for Neuropathic Pain
NCT05731739
Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy Volunteers
NCT04114656
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..
NCT01200524
Topographical Distribution of Itch and Pain Receptors
NCT07122973
NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain
NCT00258622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Levcromakalim
To investigate the role of levcromakalim compared with placebo after intradermal and intramuscular injection.
To give 0,05 ml intradermal and 0.2 intramuscular of 150 ug/ml levcromakalim after baseline time 0.
Levcromakalim
To investigate the role of levcromakalim compared with placebo after intradermal and intramuscular injection.
Saline
To investigate the role of levcromakalim compared with placebo after intradermal and intramuscular injection.
Saline
To investigate the role of levcromakalim compared with placebo after intradermal and intramuscular injection.
To give 0,05 ml intradermal and 0.2 intramuscular of saline after baseline time 0.
Levcromakalim
To investigate the role of levcromakalim compared with placebo after intradermal and intramuscular injection.
Saline
To investigate the role of levcromakalim compared with placebo after intradermal and intramuscular injection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Levcromakalim
To investigate the role of levcromakalim compared with placebo after intradermal and intramuscular injection.
Saline
To investigate the role of levcromakalim compared with placebo after intradermal and intramuscular injection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 18-60 years.
3. 50-100 kg.
4. Women of childbearing potential must use adequate contraception.
Exclusion Criteria
2. Migraine or any other type of headache (except episodic tension-type headache less than once a month)
3. Daily intake of any medication except contraceptives
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danish Headache Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammad Al-Mahdi Al-Karagholi
MD, PhD student, Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Danish headache center
Glostrup Municipality, Copenhagen, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Levcromakalim local injection
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.